IL235287A0 - Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders - Google Patents

Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

Info

Publication number
IL235287A0
IL235287A0 IL235287A IL23528714A IL235287A0 IL 235287 A0 IL235287 A0 IL 235287A0 IL 235287 A IL235287 A IL 235287A IL 23528714 A IL23528714 A IL 23528714A IL 235287 A0 IL235287 A0 IL 235287A0
Authority
IL
Israel
Prior art keywords
treatment
improved characteristics
neuromuscular disorders
modulating oligonucleotides
rna modulating
Prior art date
Application number
IL235287A
Other languages
Hebrew (he)
Inventor
Christian De Visser Peter
Allegonda Maria Mulders Susan
Original Assignee
Christian De Visser Peter
Allegonda Maria Mulders Susan
Biomarin Tech Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NL2013/050306 external-priority patent/WO2013162363A1/en
Application filed by Christian De Visser Peter, Allegonda Maria Mulders Susan, Biomarin Tech Bv filed Critical Christian De Visser Peter
Publication of IL235287A0 publication Critical patent/IL235287A0/en

Links

IL235287A 2012-04-23 2014-10-22 Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders IL235287A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636914P 2012-04-23 2012-04-23
EP12165139 2012-04-23
PCT/NL2013/050306 WO2013162363A1 (en) 2012-04-23 2013-04-23 RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

Publications (1)

Publication Number Publication Date
IL235287A0 true IL235287A0 (en) 2014-12-31

Family

ID=66624926

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235287A IL235287A0 (en) 2012-04-23 2014-10-22 Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

Country Status (3)

Country Link
CY (1) CY1121358T1 (en)
HK (1) HK1243733A1 (en)
IL (1) IL235287A0 (en)

Also Published As

Publication number Publication date
HK1243733A1 (en) 2018-07-20
CY1121358T1 (en) 2020-05-29

Similar Documents

Publication Publication Date Title
HRP20171254T1 (en) Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
IL266159A (en) Treatment of circadian rhythm disorders
HK1209456A1 (en) Oligonucleotide for the treatment of muscular dystrophy patients
IL263661A (en) Combination therapy for the treatment of glioblastoma
IL233714A0 (en) Treatment of circadian rhythm disorders
EP2827856A4 (en) Compounds and compositions for the treatment of muscular disorders
EP2819703A4 (en) Pain treatment
LT2838539T (en) Estrogenic derivatives for use in the treatment of neurological disorders.
HK1215173A1 (en) Methods of treating s. aureus-associated diseases
EP2720708A4 (en) Targeting the neuromuscular junction for treatment
HK1201878A1 (en) Oligonucleotides for modulating gene expression and uses thereof
HK1203054A1 (en) Dinuceloside polyphosphates for the treatment of pain
ZA201408060B (en) Compositions and methods for the treatment of neurological disorders
ZA201408061B (en) Compositions and methods for the treatment of neurological disorders
HK1243733A1 (en) Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
EP2846796A4 (en) Methods of maintaining, treating or improving cognitive function
HK1214293A1 (en) C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders c-myc
AU2012900796A0 (en) Pain treatment
GB201212604D0 (en) New treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed